Europe Peripheral Vascular Devices Market Key Players, Growth, Trends, Share, Opportunities, Forecast 2028

The Europe peripheral vascular devices market is expected to grow from US$ 3,288.55 million in 2021 to US$ 5,035.19 million by 2028; it is estimated to register a CAGR of 6.3% from 2021 to 2028

The Europe peripheral vascular devices market is expected to grow from US$ 3,288.55 million in 2021 to US$ 5,035.19 million by 2028; it is estimated to register a CAGR of 6.3% from 2021 to 2028. The alarming rise in peripheral artery diseases has been a primary concern across the region. Atherosclerosis, smoking, alcoholism, and obesity are the major factors that increase the risk of developing these diseases. Further, atherosclerosis is a condition in which fatty deposits build up on the inside walls of the arteries, reducing blood flow. Healthy people over the age of 40 have a 50% chance of getting severe atherosclerosis, with the risk increasing as they get older. The disease mostly affects people over the age of 60, yet it goes unnoticed frequently. The increasing prevalence of atherosclerosis is boosting the peripheral vascular devices market substantially.

📚 Download Sample PDF Copy@ https://www.businessmarketinsights.com/sample/BMIRE00025627

As per the WHO, in 2021, ~1.13 billion people were suffering from hypertension, a leading cause of premature death. Obesity is associated with high blood pressure, dyslipidemia, diabetes or insulin resistance, and higher fibrinogen and C-reactive protein levels, which increase the risk of cardiovascular diseases. Obesity has been associated with a greater risk of high blood pressure. A few significant players are developing and introducing novel products and technologies to compete with existing products in the market, while others are acquiring and partnering with other companies. Thus, the increasing prevalence of hypertension, smoking, alcoholism, and obesity requiring mobility assistance is contributing to the growth of the market across the region.With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe peripheral vascular devices market at a notable CAGR during the forecast period.

Europe Peripheral Vascular Devices Market Segmentation

The Europe peripheral vascular devices market is segmented into product, end user, and country. Based on product, the Europe peripheral vascular devices market is segmented into peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, and embolization guidewires. Further, the peripheral vascular stents segment dominated the market in 2021. Based on end user, the Europe peripheral vascular devices market is segmented into hospitals & clinics, ambulatory care centers, specialty clinics, and others. Further, the hospitals & clinics segment dominated the market in 2021. Based on country, the Europe peripheral vascular devices market is segmented into France, Germany, France, the UK, Italy, Spain, and the Rest of Europe. Further, Germany dominated the market in 2021. Abbott, B. Braun Melsungen AG, BD, Boston Scientific Co Europe Peripheral Vascular Devices Market rporation, Cardinal Health Inc, Cook Medical LLC, Edwards Lifesciences Corporation, Medtronic, Teleflex Incorporated, and Terumo Corporation are among the leading companies operating in the Europe peripheral vascular devices market.

📚Full Report Link @ https://www.businessmarketinsights.com/reports/europe-peripheral-vascular-devices-market

The List of Companies

Abbott

Braun Melsungen AG
BD

Boston Scientific Corporation

Cardinal Health Inc

Cook Medical LLC

Edwards Lifesciences Corporation

Medtronic

Teleflex Incorporated

Terumo Corporation

Segments Covered

By Product

Peripheral Vascular Stents
Peripheral Transluminal Angioplasty Balloon Catheters
PTA Guidewires
Atherectomy Devices
Chronic Total Occlusion Devices
Aortic Stents
Synthetic Surgical Grafts
Embolization Guidewires
By End User

Hospitals & Clinics
Ambulatory Care Centers
Specialty Clinics

In addition to atherosclerosis, other lifestyle factors like smoking, alcoholism, and obesity are also major contributors to the development of peripheral vascular diseases. According to the World Health Organization (WHO), approximately 1.13 billion people were living with hypertension in 2021, which is a leading cause of premature death worldwide. Obesity, in particular, has been closely linked to several conditions that increase the risk of cardiovascular diseases, including high blood pressure, diabetes, insulin resistance, and elevated levels of inflammatory markers such as fibrinogen and C-reactive protein. Obesity not only increases the risk of developing hypertension but also exacerbates other cardiovascular conditions, further driving the demand for medical devices that aid in managing these diseases.

As a result of these factors, there is an increasing need for effective peripheral vascular devices. These devices are essential in diagnosing, treating, and monitoring peripheral vascular diseases, particularly for patients suffering from atherosclerosis and its associated complications. Peripheral vascular devices, such as stents, angioplasty balloons, atherectomy devices, and compression devices, are critical in improving blood flow, preventing complications, and enhancing patient outcomes.

In response to the growing demand for these devices, several major companies are investing in the development of innovative products and technologies to remain competitive in the market. Some companies are focusing on research and development (R&D) to introduce new technologies that offer better treatment outcomes, while others are expanding their market presence through strategic acquisitions and partnerships with other medical device companies. By improving the effectiveness and accessibility of peripheral vascular devices, these companies aim to capitalize on the rising demand driven by the increasing prevalence of cardiovascular diseases.

The increasing prevalence of hypertension, smoking, alcoholism, and obesity - factors that necessitate mobility assistance - further contribute to the market's expansion across Europe. With these conditions affecting a significant portion of the population, the market for peripheral vascular devices is poised for continued growth, as healthcare providers seek better solutions to manage and treat these conditions effectively. Additionally, the aging population in Europe, particularly individuals over the age of 60, is expected to continue driving demand for these devices, as older adults are more likely to suffer from vascular diseases like PAD and atherosclerosis.

In conclusion, the Europe peripheral vascular devices market is set to grow significantly over the next several years, fueled by the rising incidence of peripheral artery diseases, lifestyle factors such as obesity and smoking, and the aging population. The development of advanced medical devices and technologies by key players in the industry will play a crucial role in addressing these growing healthcare challenges. As the prevalence of cardiovascular diseases continues to rise, the demand for peripheral vascular devices will remain robust, supporting the market's growth trajectory throughout the forecast period.

You can see this-
North America Medical Tubing Market- https://www.openpr.com/news/3913164/north-america-medical-tubing-market-global-analysis-with-focus
Europe Baking Ingredients Market- https://www.openpr.com/news/3913804/europe-baking-ingredients-market-size-share-opportunities
Europe Recycled Glass Market- https://www.openpr.com/news/3914682/europe-recycled-glass-market-statistics-trends-size-share

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

This release was published on openPR.